Systimmune
This on-site Scientist role within the Immuno-Oncology Research and Development group supports discovery-stage programs through the execution of in vitro experiments, immune cell-based assays, and advanced imaging workflows. The ideal candidate will utilize a strong experimental background in cellular and molecular biology to develop therapeutic antibody discovery and characterization methods in a BSL-2 laboratory environment.
Headquarters
Redmond, Washington, United States
Company Size
11-50 employees
Founded
2014
SystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Systimmune.
27% below the average for this role
Senior Principal Scientist, In Vitro Pharmacology
Flagship Pioneering, Inc.
Research Associate (Contractor), Cell Therapy
Obsidian Therapeutics
Scientist- Cancer Immunology/Immunotherapy
AstraZeneca
Scientist, Macrophage and Myeloid Biology
engitix
Senior Scientist
c10labs
Associate Scientist, Therapeutic Antibodies
Regeneron Pharmaceuticals